Response to hepatitis B vaccine: multiple HLA genes are involved
- 1 June 1998
- journal article
- Published by Wiley in Tissue Antigens
- Vol. 51 (6) , 593-604
- https://doi.org/10.1111/j.1399-0039.1998.tb03001.x
Abstract
The mechanism underlying the impaired immune response to hepatitis B vaccines in up to 10% of healthy subjects is not known. An increased incidence of poor responsiveness in subjects with HLA-DR3+ or -DR7+ haplotypes has been documented, suggesting that HLA-DR-linked genes may regulate the human response to hepatitis B surface antigen. However, not all HLA-DR3+ and/or -DR7+ individuals are poor responders, and subjects with identical HLA-DR haplotypes sometimes display totally divergent antibody responses to vaccination. HLA class II DNA typing was performed in well and poorly responding hepatitis B vaccine recipients and we analyzed the role of the single HLA-DR, -DP, and -DQ molecules and of their associated (interaction) haplotypes in the response to hepatitis B vaccination. Statistical analysis revealed that HLA-DRB1*010*, -DR5, -DPB1*040*, -DQB1*0301, and -DQB1*0501 were more abundant in good responders, whereas HLA-DRB1*07, -DPB1*1101, and -DQB1*020* were associated with poor response, with DQB1*020* showing the strongest association with poor responsiveness. We further investigated whether there were interactions between the HLA factors contributing to poor responsiveness. We show here that HLA-DPB1*02 was negatively associated with responsiveness when it occurred in association with haplotype DRB1*0701/DRB4*0101-DQB1*020*, and DRB4*0101 was negatively associated with responsiveness when it occurred in association with haplotype DRB1*0301/DRB3*0101-DQB1*020*. Our results indicate that the immune response to hepatitis B vaccine is largely determined by HLA-DR, -DP, and -DQ genes and that interaction between HLA molecules that are not in linkage disequilibrium contributes to poor responsiveness.Keywords
This publication has 28 references indexed in Scilit:
- Is Nonresponsiveness to Hepatitis B Vaccine Due to Latent Hepatitis B Virus Infection?The Journal of Infectious Diseases, 1992
- Strong linkage disequilibrium of HLA DPw11 with the HLA B44‐DR7‐DQw2 extended haplotype*Tissue Antigens, 1992
- Prevention and Therapy of Viral HepatitisSeminars in Liver Disease, 1991
- HLA‐associated non‐responsiveness to Hepatitis B vaccineTissue Antigens, 1990
- Genetic Prediction of Nonresponse to Hepatitis B VaccineNew England Journal of Medicine, 1989
- Immune suppression gene on HLA-Bw54-DR4-DRw53 haplotype controls nonresponsiveness in humans to hepatitis B surface antigen via CD8+ suppressor T cellsHuman Immunology, 1988
- Humoral Immune Response After Hepatitis-B-Vaccination: Kinetics of Anti-HBS Antibodies and Demonstration of HLA AntigensZentralblatt für Bakteriologie, Mikrobiologie und Hygiene. Series A: Medical Microbiology, Infectious Diseases, Virology, Parasitology, 1986
- Recognition of DP determinants with typing reagents prepared with lymphocytes from Dutch unrelated individualsTissue Antigens, 1985
- Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). IV. Distinct H-2-linked Ir genes control antibody responses to different HBsAg determinants on the same molecule and map to the I-A and I-C subregions.The Journal of Experimental Medicine, 1984
- ON ESTIMATING THE RELATION BETWEEN BLOOD GROUP AND DISEASEAnnals of Human Genetics, 1955